Hillrom (NYSE:HRC) shares dipped today on first-quarter results that fell short of last year’s numbers but still topped the consensus forecast. The Chicago-based company posted profits of $39.8 million, or 59¢ per share, on sales of $685 million for the three months ended Dec. 31, 2019, for a 5.7% bottom-line slide on sales growth of 0.15%. […]
Baxter rises after Street-beating preliminary 4Q sales results
Baxter (NYSE:BAX) shares were up today after the company reported preliminary net sales for the fourth quarter of fiscal 2019 that topped the Wall Street consensus. The Deerfield, Ill.-based company posted net sales of $3 billion for the fourth quarter, marking 7% growth on a reported basis and 9% growth on an operational basis. That number […]
iRhythm releases delayed Q3 earnings report, falls short of Street projections
iRhythm Technologies (NSDQ:IRTC) shares are slightly up today on third-quarter results that came up short of the consensus forecast. The San Francisco-based company delayed its third-quarter report in November due to a previously disclosed material weaknesses. At the time, the company said it identified errors that affected prior periods while preparing the quarterly report for the […]
Varian Medical spending extra on Endocare and Alicon purchase
Radiation oncology treatments and software maker Varian Medical Systems (NYSE:VAR) announced today that it updated its previously reported GAAP preliminary financial results for the fourth quarter and fiscal 2019. Earlier this week, the company uncovered new information and determined that the financial performance of its recently acquired Endocare and Alicon business was better than previously understood […]
Ishrak backs Martha for success on Medtronic earnings call
Medtronic (NYSE:MDT) outgoing CEO Omar Ishrak said on the company’s latest earnings call that his successor Geoff Martha is poised to prosper in the role, having already taken over as president and being given a seat on the board this month. The Fridley, Minn.–based company announced in August that Martha would take over for Ishrak, who […]
Medtronic Q2 results beat The Street
Medtronic (NYSE:MDT) posted second-quarter results today that beat the consensus forecast on Wall Street and reiterated its outlook for the rest of the fiscal year. The Fridley, Minn.–based company reported profits of $1.4 billion, or $1.01 per share, on sales of $7.7 billion for the three months ended Oct. 25, 2019, for a bottom-line gain of […]
ReShape loses profits, grows sales in Q3
ReShape Lifesciences (OTC:RSLS) posted large bottom-line losses in the third quarter, despite a big leap in sales growth. The San Clemente, Calif.–based obesity and metabolic disease treatment developer posted losses of -$28.8 million, or $-106.55 per share, on sales of $3.5 million for the three months ended Sept. 30, for a massive bottom-line slide on […]
ReWalk Robotics posts Q3 losses on missed projections
ReWalk Robotics (NSDQ:RWLK) reported third-quarter results that came up shy of the consensus forecast. The Yokneam Illit, Israel–based robotic walking assistance company posted losses of -$3.4 million, or -46¢ per share, on sales of $1.2 million for the three months ended Sept. 30, for a 25.2% bottom-line gain on sales decline of -23.7%. Adjusted to exclude […]
Biolase beats Street despite Q3 losses
Biolase (NSDQ:BIOL) shares hit a slight uptick on third-quarter results that topped the consensus forecast in spite of revenue and profit dips. The Irvine, Calif.-based laser system developer earlier this month posted losses of -$5.5 million, or -25¢ per share, on sales of $8.6 million for the three months ended Sept. 30, for a 17.4% bottom-line […]
Myomo slides on missed Q3 projections
Myomo (NYSE:MYO) shares plummeted today on third-quarter sales shortcomings and a bottom-line dip. The Cambridge, Mass.–based wearable medical robotics company posted losses of -$2.8 million, or -16¢ per share, on sales of $606,619 for the three months ended Sept. 30, for a 5.2% bottom-line slide on a sales decline of 0.4%. Adjusted to exclude one-time […]
TransEnterix slashes workforce amid disappointing Q3 results
TransEnterix (NYSE:TRXC) has let go of 39 employees, 18% of its headcount, as the robot-assisted surgery company turns its focus on existing Sehance system customers versus drumming up sales. “Our key areas of focus in 2020 will be on market develop activities, expanding the clinical economic evidence, supporting Senhance and adding important new features, such as […]
- 1
- 2
- 3
- …
- 228
- Next Page »
MassDevice Network
@MassDevice
LinkedIn
YouTube